HbF CELMoD

N/A

Report date: 2025/12/30 09:44:51

Base Information

Drug NameHbF CELMoD
Drug Alias NameHbF Activating CELMoD
ClassificationSmall molecules > Molecular Glue
Mechanisms of ActionHemoglobins modulatorsCereblon modulatorsE3 ubiquitin-protein ligase HECTD1 modulators
TargetsHemoglobinsCereblonE3 ubiquitin-protein ligase HECTD1
Therapy Area/IndicationsAnemia, Sickle Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesBristol-Myers Squibb Company
Inactive CompaniesN/A
Active IndicationsAnemia, Sickle Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A